BDBM342487 US9776988, Example 3

SMILES COc1cc(CCc2cc(-c3nc4ccc(C(=O)NC5CCOCC5)cc4[nH]3)n[nH]2)cc(OC)c1

InChI Key InChIKey=WRLCMSJRWBXEIO-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 342487   

TargetFibroblast growth factor receptor 2(Human)
Celon Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 342487BDBM342487(US9776988, Example 3)
Affinity DataIC50: 1.07nMAssay Description:The compounds were dissolved in 100% DMSO, and obtained solutions were serially diluted in reaction buffer (50 mM Tris pH 7.5, 10 mM MgCl2, 0.25 mM E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2019
Entry Details
US Patent

TargetFibroblast growth factor receptor 2(Human)
Celon Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 342487BDBM342487(US9776988, Example 3)
Affinity DataIC50: 1.10nMAssay Description:Inhibition of recombinant N-terminal GST-tagged human FGFR2 (399 to 821 residues) expressed in baculovirus expression system using IGF-1Rtide peptide...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 1(Human)
Celon Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 342487BDBM342487(US9776988, Example 3)
Affinity DataIC50: 11nMAssay Description:Inhibition of recombinant N-terminal GST-tagged human FGFR1 (398 to 822 residues) expressed in baculovirus expression system using IGF-1Rtide peptide...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 1(Human)
Celon Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 342487BDBM342487(US9776988, Example 3)
Affinity DataIC50: 11.3nMAssay Description:The compounds were dissolved in 100% DMSO, and obtained solutions were serially diluted in reaction buffer (50 mM Tris pH 7.5, 10 mM MgCl2, 0.25 mM E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2019
Entry Details
US Patent

TargetFibroblast growth factor receptor 3(Human)
Celon Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 342487BDBM342487(US9776988, Example 3)
Affinity DataIC50: 40.5nMAssay Description:The compounds were dissolved in 100% DMSO, and obtained solutions were serially diluted in reaction buffer (50 mM Tris pH 7.5, 10 mM MgCl2, 0.25 mM E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2019
Entry Details
US Patent

TargetFibroblast growth factor receptor 3(Human)
Celon Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 342487BDBM342487(US9776988, Example 3)
Affinity DataIC50: 41nMAssay Description:Inhibition of recombinant human N-terminal GST-tagged FGFR3 (436 to 806 residues) expressed in baculovirus expression system using IGF-1Rtide peptide...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetVascular endothelial growth factor receptor 2(Human)
Celon Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 342487BDBM342487(US9776988, Example 3)
Affinity DataIC50: 70nMAssay Description:Inhibition of recombinant N-terminal GST-tagged human KDR (790 to 1356 residues) expressed in baculovirus expression system using IGF-1Rtide peptide ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetVascular endothelial growth factor receptor 2(Human)
Celon Pharma

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 342487BDBM342487(US9776988, Example 3)
Affinity DataIC50: 70.4nMAssay Description:The compounds were dissolved in 100% DMSO, and obtained solutions were serially diluted in reaction buffer (50 mM Tris pH 7.5, 10 mM MgCl2, 0.25 mM E...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/11/2019
Entry Details
US Patent